MDV hires pros to find personalized medicine investments
Mohr Davidow Ventures, a Menlo Park, Calif. firm, has hired two biotech experts to help it make prudent investments in personalized healthcare companies. Essentially, they will look for startups that apply technology to give patients more control over their medical experiences, and to cut costs for care providers and drug developers.
Daniel Riskin — who actually worked as a surgeon before entering industry — and Phyllis Whiteley both have firsthand experience at biotechnology companies. Riskin, named… Continue Reading
Perlegen Scienes withdraws $115M IPO
Perlegen Sciences, a Mountain View, Calf. company that develops drugs based on genetic response, withdrew its plans to raise up to $115 million in an initial public offering.
The company cited market conditions, and also problems with a $1.3 million government contract.
A spin-out from public company Affymetrix, Perlegen has raised about $256 million from a list of investors including BioOne Capital, Biofrontier Partners, Brookside Capital, BSI industries, Cape Securities, CMEA Ventures, CSK Venture Capital, Eli Lilly,… Continue Reading